Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform. - Darwanto, Agus; Hein, Anne-Mette; Strauss, Sascha; Yi Kong; Sheridan, Andrew; Richards, Dan; Lader, Eric; Ngowe, Monika; Pelletier, Timothy; Adams, Danielle; Ricker, Austin; Patel, Nishit; et al. (BMC Cancer, 2017)